CytomX Therapeutics, Inc. (CTMX)
2.56
-0.02
(-0.78%)
USD |
NASDAQ |
Oct 06, 16:00
2.60
+0.04
(+1.56%)
After-Hours: 20:00
CytomX Therapeutics Market Cap : 557.82M for Oct. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 06, 2026 | 557.82M |
| October 05, 2026 | 562.18M |
| October 02, 2026 | 557.82M |
| October 01, 2026 | 573.08M |
| September 30, 2026 | 592.69M |
| September 29, 2026 | 599.22M |
| September 28, 2026 | 586.15M |
| September 25, 2026 | 588.33M |
| September 24, 2026 | 599.22M |
| September 23, 2026 | 605.76M |
| September 22, 2026 | 640.62M |
| September 21, 2026 | 601.40M |
| September 18, 2026 | 601.40M |
| September 17, 2026 | 614.48M |
| September 16, 2026 | 602.49M |
| September 15, 2026 | 586.15M |
| September 14, 2026 | 697.28M |
| September 11, 2026 | 716.89M |
| September 10, 2026 | 729.96M |
| September 09, 2026 | 771.36M |
| September 08, 2026 | 795.33M |
| September 04, 2026 | 808.41M |
| September 03, 2026 | 801.87M |
| September 02, 2026 | 810.59M |
| September 01, 2026 | 799.69M |
| Date | Value |
|---|---|
| August 31, 2026 | 732.14M |
| August 28, 2026 | 699.46M |
| August 27, 2026 | 745.22M |
| August 26, 2026 | 723.43M |
| August 25, 2026 | 734.32M |
| August 24, 2026 | 716.89M |
| August 21, 2026 | 714.71M |
| August 20, 2026 | 716.89M |
| August 19, 2026 | 777.90M |
| August 18, 2026 | 738.68M |
| August 17, 2026 | 751.75M |
| August 14, 2026 | 732.14M |
| August 13, 2026 | 729.96M |
| August 12, 2026 | 760.47M |
| August 11, 2026 | 751.75M |
| August 10, 2026 | 749.57M |
| August 07, 2026 | 753.93M |
| August 06, 2026 | 734.32M |
| August 05, 2026 | 729.96M |
| August 04, 2026 | 723.43M |
| August 03, 2026 | 690.09M |
| July 31, 2026 | 674.85M |
| July 30, 2026 | 714.04M |
| July 29, 2026 | 690.09M |
| July 28, 2026 | 700.97M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 76.38B |
| ACADIA Pharmaceuticals, Inc. | 3.398B |
| Alnylam Pharmaceuticals, Inc. | 29.95B |
| Savara, Inc. | 955.11M |
| Vericel Corp. | 2.049B |
Market Cap Related Metrics
| PS Ratio | 25.58 |
| Price to Book Value | 1.847 |
| Price | 2.56 |
| Earnings Yield | -17.85% |